Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Bullboard Posts
Comment by retiredcopon May 09, 2018 8:58am
145 Views
Post# 28003273

RE:Sale

RE:SaleMay 1, 2018
 “ Noble Capital Markets, Inc., which acted as placement agent for subscribers in the United States, “
Noble Capital Markets, Inc. operates as a brokerage firm. The Company buys and sells securities such as stocks, bonds, mutual funds, and other investment products, as well as offers investment banking, research, and advisory services. Noble Capital Markets serves customers in the United States.

Go to their web ste and you will see the services they offer... they have the ability to promote a company vey well and the type of credibility PMN needs ... very high proile and lots of exposure especially in the USA. 

Reagrding a sale or partnership... I agree either of those scenerios is possible... its just me persoanlly that likes the "sale aspect " After 12 years ....I really am looking forward to an exit with a huge BANG ...    
Bullboard Posts